SignalCorporate

FTC and 7 states are seeking to hold Martin Shkreli in contempt over pharma ban

FTC and seven states seek contempt ruling against Shkreli over pharma ban violation.

Context

What happened: The FTC and 7 states are seeking to hold Martin Shkreli in contempt over a pharma ban. The agency alleges he traded stock in at least 60 pharmaceutical companies and broadcast investment advice online since his 2022 release from prison. Key numbers: 7 states, at least 60 pharmaceutical companies, 2022 release from prison. Why it matters: The filing claims Shkreli's trading and online investment advice violated the terms of his ban, which the FTC and the states are asking a court to enforce through contempt. Coverage: 9 outlets in 24h

What changed

The FTC and 7 states are seeking to hold Martin Shkreli in contempt over a pharma ban. The agency alleges he traded stock in at least 60 pharmaceutical companies and broadcast investment advice online since his 2022 release from prison.

Why it matters

The filing claims Shkreli's trading and online investment advice violated the terms of his ban, which the FTC and the states are asking a court to enforce through contempt.

Sources